Australian Public Assessment
Reports have been released for
three more therapies, with the TGA
website now including AusPARS for
Zaltrap/Aflitiv/Lidaveg (aflibercept),
Daivobet 50/500 (calcipotriol and
betamethasone) and Cinryze (C1
esterase inhibitor).The above article was sent to subscribers in Pharmacy Daily's issue from 17 Oct 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Oct 13
FROM Monday next week, it will be unlawful to supply, manufacture, import, and sell a vape outside of a pharmacy, according to the Federal Health Minister Mark Butler (pictured).
US-BASED pharmaceutical company Eli Lilly has announced it is in collaboration with OpenAI to harness generative AI for developing antimicrobials to combat drug-resistant bacteria, reported Reuters.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.